REBECCA POAGE: Open Payments
NPI 1811539372 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 35 payments from 14 companies in 2025. Trend: 2023 $934 · 2024 $987 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $248 |
| PFIZER INC. | 9 | $145 |
| Novo Nordisk Inc | 4 | $70 |
| Amgen Inc. | 3 | $64 |
| Lilly USA, LLC | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Ascensia Diabetes Care Us Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: AIRSUPRA, NURTEC ODT, MOUNJARO, TRELEGY ELLIPTA, PREVNAR 20, OTEZLA, KRYSTEXXA, ELIQUIS.
Industry payments across MO — which companies pay providers there.
